TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
33,85 USD
0,00%
(0,00) 1D
6-окт., 11:51:40 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TKPHF...
Mkt. cap
59,21 млд
Avg. vol.
2,49 миң
Volume
0,00
52-wk high
39,20 USD
52-wk low
26,33 USD
Beta
-2,60
Shares outstanding
1,60 млд
No. of employees
47 миң
Mkt. cap
59,21 млд
Avg. vol.
2,49 миң
Volume
0,00
52-wk high
39,20 USD
52-wk low
26,33 USD
Beta
-2,60
Shares outstanding
1,60 млд
No. of employees
47 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
5 саат мурун
TAK stock costs EUR 16.80 with a P/ E ratio of 52.1
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47 миң
Founded1781-ж., 12-июн.
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com